Dual-energy CT for differentiating gastric gastrointestinal stromal tumors from leiomyomas
To evaluate the diagnostic value and reproducibility of quantitative dual-source dual-energy CT (dsDECT) parameters for differentiating 0.5–4.0 cm gastric GISTs from leiomyomas. This prospective study included patients with pathologically confirmed gastric GISTs (n = 61) or leiomyomas (n = 42) measuring 0.5–4.0 cm who underwent contrast-enhanced dsDECT between August 2025 and June 2026. Quantitative parameters, including IC, NIC, λHU, and Z, were compared between the two groups. Interobserver reproducibility was assessed using intraclass correlation coefficients (ICCs). Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis. Multivariable logistic regression was performed to determine whether VP IC remained independently associated with GIST after adjustment for relevant clinical and conventional imaging characteristics. VP parameters showed the most consistent discriminatory differences. VP IC, VP NIC, VP λHU, and VP Z were significantly higher in GISTs than in leiomyomas after false discovery rate correction. Among all evaluated dsDECT parameters, VP IC exhibited the highest diagnostic performance (AUC = 0.809; 95% CI, 0.723–0.894). At an optimal cutoff of 1.45 mg/mL, VP IC achieved an accuracy of 72.8%, a sensitivity of 62.3%, a specificity of 88.1%, and a positive predictive value of 88.4%. VP IC remained independently associated with GIST after adjustment for age, sex, CT maximum diameter, and growth pattern (adjusted odds ratio [aOR], 9.86; 95% CI, 3.73–33.65; P < 0.001). Interobserver agreement for VP IC was excellent (ICC, 0.962; 95% CI, 0.945–0.974). Addition of VP Z did not significantly improve discrimination compared with VP IC alone (AUC, 0.816 vs. 0.809; DeLong P = 0.510). Quantitative dsDECT parameters, VP IC provide reproducible noninvasive information for differentiating gastric GISTs from leiomyomas. VP IC showed moderate sensitivity and high specificity and remained independently associated with GIST after clinical adjustment. External validation is warranted before routine clinical implementation.
Authors
- 张玉忠
- Linna Wu
- Li-juan Wei
- Si-wen Liu
- Xin Chen
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41598-026-76023-9
- Primary Topic
- Gastrointestinal Tumor Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00